Background: There are limited clinical studies of bilateral vertebral artery dissection (VAD).
Objective: To compare the characteristics, imaging findings, and treatments between patients with bilateral and unilateral VAD.
Methods: Between February 2007 and May 2017, 31 (mean age: 53.0 years; 23 men, 8 women) out of 171 VAD patients were hospitalized because of bilateral VAD. Onset type, dissection site, dominant side of the VA, imaging features, treatments, and outcomes were investigated based on medical records. The dominant side of the VA was determined by basi-parallel anatomical scanning.
Results: Twenty (64.5%) of 31 patients exhibited bilateral VAD on both sides of V4. The dominant side of the VA was right in 16 patients and left in 15 patients. The pearl and string sign (an angiographical finding with both dilatation and stenosis) was frequently observed on the dominant VAD side, while a tapered occlusion and string sign were most common on the nondominant side. For clinical subtype of VAD, 6 (19.4%) patients had subarachnoid hemorrhage, 10 (32.3%) ischemic stroke, 3 (9.7%) infarction plus subarachnoid hemorrhage, and 12 (38.7%) only headache. The frequency of infarction was increased in bilateral VAD compared with unilateral (P < .05). Surgical intervention was performed in 3 cases, while 14 patients received endovascular intervention.
Conclusions: Infarction occurred frequently in bilateral VAD patients, and 17 patients required an intervention (mainly endovascular) for VA. The treatment strategy varied depending on the clinical subtype, imaging findings of VAD, and morphology of the dominant VAD side.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2019.01.009 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Molecular Hydrogen Modulates T Cell Differentiation and Enhances Neuro-Regeneration in a Vascular Dementia Mouse Model.
Antioxidants (Basel)
January 2025
Department of Neurosurgery, Korea University Ansan Hospital, Korea University College of Medicine, 123 Jeokgeum-ro, Ansan 15355, Republic of Korea.
This study explores whether molecular hydrogen (H) administration can alleviate cognitive and immunological disturbances in a mouse model of vascular dementia (VaD). Adult male C57BL/6 mice underwent bilateral common carotid artery stenosis to induce VaD and were subsequently assigned to three groups: VaD, VaD with hydrogen-rich water treatment (VaD + H), and Sham controls. Behavioral assessments using open field and novel object recognition tests revealed that VaD mice exhibited anxiety-deficient behavior and memory impairment, both of which were reversed by H treatment.
View Article and Find Full Text PDFBackground: As a key inflammatory factor, the nucleotide-binding oligomerization domain (NOD)-like receptor protein 3 (NLRP3) inflammasome plays a crucial role in neuroinflammation and the progression of neurodegenerative diseases. Dysregulation of NLRP3 signaling can trigger various inflammatory responses in the brain, contributing to the development of neurodegenerative diseases such as ischemic stroke, vascular dementia (VaD), Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS). Therefore, the NLRP3 signaling pathway is a promising therapeutic target for the treatment of neurodegenerative diseases, including VaD.
View Article and Find Full Text PDFAnti-RGMa neutralizing antibody ameliorates vascular cognitive impairment in mice.
Neurotherapeutics
November 2024
Department of Molecular Neuroscience, Graduate School of Medicine, Osaka University, Suita, Japan; Department of Neuro-Medical Science, Graduate School of Medicine, Osaka University, Suita, Japan; WPI-Immunology Frontier Research Center, Osaka University, Suita, Japan. Electronic address:
Article Synopsis
- Repulsive Guidance Molecule A (RGMa) is important for guiding nerve connections and has shown various functions in brain diseases like spinal cord injury and Parkinson's disease.
- In this study, RGMa's role was investigated in a mouse model of vascular dementia (VaD), where it was found to be overexpressed in the hippocampus, leading to cognitive decline.
- Treatment with an anti-RGMa neutralizing antibody not only improved cognitive function but also reversed the negative effects of RGMa on neurogenesis and cholinergic innervation, indicating a potential new treatment for VaD.
Impairment of Neurovascular Function in Intermediate Age-Related Macular Degeneration.
Transl Vis Sci Technol
November 2024
Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne, Australia.
Purpose: To investigate neurovascular function in eyes with age-related macular degeneration (AMD).
Methods: Subjects with bilateral large drusen (intermediate AMD) and healthy controls ≥50 years old were recruited. The vasculature within the central 6 × 6-mm retinal area was captured using optical coherence tomography angiography (OCTA) and segmented to return superficial plexus, deep plexus, choriocapillaris, and choroid.
High-resolution magnetic resonance imaging in the diagnosis and management of vertebral artery dissection: A case report.
World J Radiol
October 2024
Department of Neurosurgery, The Second Affiliated Hospital of University of South China, Hengyang 421001, Hunan Province, China.
Article Synopsis
- Vertebral artery dissection (VAD) is a rare but serious condition caused by tearing in the vertebral artery, leading to symptoms like headache and dizziness, and requires timely diagnosis for better outcomes.
- A young male patient experienced severe headache and seizures, and imaging revealed bilateral VAD and complications like brainstem infarcts, but digital subtraction angiography missed the dissection.
- High-resolution magnetic resonance imaging (HRMRI) successfully confirmed the diagnosis of VAD and supported the patient's treatment plan, ultimately leading to significant recovery after rehabilitation.*
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!